| Michelle Dianne Pelletier, LPN | |
|
8495 Crater Lake Hwy, White City, OR 97503-3011 | |
| (541) 826-2111 | |
| (541) 830-3526 |
| Full Name | Michelle Dianne Pelletier |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 8495 Crater Lake Hwy, White City, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497492474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 200730445LPN (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Dianne Pelletier, LPN 8495 Crater Lake Hwy, White City, OR 97503-3011 Ph: (541) 826-2111 | Michelle Dianne Pelletier, LPN 8495 Crater Lake Hwy, White City, OR 97503-3011 Ph: (541) 826-2111 |
News Archive
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced plans to submit a Phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of 2010. The Company has added the talent of Peter G. Traber, M.D., to its FDA approval strategy and trial design team.
BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the approval from the French Drug Agency (AFSSaPS) to enter first Phase I clinical trial for Fentanyl Lauriad®.
According to a Mintel survey of adult men, those who are married are more likely to have had a physical with a registered physician within the past year compared to their single counterparts (55% versus 35%).
The Mount Sinai School of Medicine will collaborate with the prestigious Bionostra Group of Spain to develop an avian flu vaccine. The vaccine will protect against the lethal infection of the H5N1 virus.
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
› Verified 2 days ago
Mrs. Ethel Lynne Giesbrecht, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8495 Crater Lake Hwy Rm 168, White City, OR 97503 Phone: 541-826-2111 Fax: 541-830-7424 | |
Jennifer M Thomas, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8495 Crater Lake Hwy, White City, OR 97503 Phone: 541-826-2111 | |
Leslye Williams Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8495 Crater Lake Hwy, White City, OR 97503 Phone: 541-826-2111 | |
Rosa Michelle Easley, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8495 Crater Lake Hwy, White City, OR 97503 Phone: 541-826-2111 Fax: 541-830-3511 |